Eaton Financial Holdings’s AbbVie ABBV Stock Holding History

Eaton Financial Holdings’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$708K	Sell	2,813 -965	-26%	-$208K	0.19%	83
2026 Q1	$822K	Sell	3,778 -958	-20%	-$213K	0.27%	73
2025 Q4	$1.08M	Sell	4,736 -539	-10%	-$123K	0.29%	64
2025 Q3	$1.22M	Sell	5,275 -1,502	-22%	-$306K	0.34%	56
2025 Q2	$1.26M	Buy	+6,777	New	+$1.26M	0.39%	45
2023 Q2	–	Sell	-1,455	Closed	-$232K	–	53
2023 Q1	$232K	Sell	1,455 -178	-11%	-$27.2K	0.18%	50
2022 Q4	$264K	Buy	+1,633	New	+$250K	0.23%	58

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Eaton Financial Holdings's ABBV Position: Q2 2026 in Review

Eaton Financial Holdings reduced its AbbVie (ABBV) stake by 26% in Q2 2026, selling an estimated $208K and leaving 2,813 shares worth $708K. The position accounts for 0.19% of the portfolio, ranked #83.

Eaton Financial Holdings first reported a position in ABBV in Q4 2022 and has held it in 7 quarters since. The position peaked at $1.26M in Q2 2025. 4,195 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Eaton Financial Holdings held 2,813 shares of AbbVie worth $708K as of Q2 2026.
Eaton Financial Holdings sold 965 AbbVie shares in Q2 2026, an estimated $208K.
AbbVie made up 0.19% of Eaton Financial Holdings's portfolio in Q2 2026, its #83 holding.
Eaton Financial Holdings first reported a position in AbbVie in Q4 2022 and has held it in 7 quarters since.
Eaton Financial Holdings's AbbVie position peaked at $1.26M in Q2 2025.
4,195 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Eaton Financial Holdings's 13F filing for Q2 2026, filed 5 Aug 2026.